Why the study?
Does low-dose aspirin increase the risk of upper gastrointestinal complications in patients with different baseline gastrointestinal risk profiles?
Does low-dose aspirin increase the risk of upper gastrointestinal complications in patients with different baseline gastrointestinal risk profiles?
The gastrointestinal harms of low-dose aspirin may offset its cardiovascular benefits in patients with high gastrointestinal and low cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
May warrant individualized GI risk assessment before aspirin; leaves open net benefit in high-GI/low-CV patients.
A 2006 study studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: